SightGlass Vision Reports 18-month DOT Lens Data Showing Reduced Myopia Progression
New readout at Academy ’25 adds weight to contrast-modulating spectacle lenses SightGlass Vision (San Ramon, CA, United States) brought fresh…
FDA Clears Immunoglobulin Eye Drops for Phase II Dry Eye Trial
Biologic therapy enters clinical study to assess broad anti-inflammatory potential The U.S. FDA has granted IND clearance for a new…
latest posts
